We discovered that IκBα was phosphorylated by RSK3 binding; inhibition of the RSK3/IκBα interaction could decrease NF-κB activation, and thereby increase the rate of apoptosis in cancer cells. The gene discussed is NFKBIA; the disease is cancer.